Themed Discussion

People living with HIV: thinking of QoL

TD 1
Efficacy, safety and metabolic changes at 6-months after switch to long-acting injectable CAB/RPV: results from an observational prospective multicenter study

TD 2
Patient-reported outcomes (PROs) in people living with HIV treated with long-acting injectable antiretroviral therapy (LAI-ART)

TD 3
Enhancing adherence and treatment satisfaction in people living with HIV: the impact of cabotegravir plus rilpivirine long-acting in real life

TD 4
Clinical experience with Doravirine: real-life study of therapeutic efficacy and influence on metabolic profile of dual versus triple antiretroviral regimens in a tertiary hospital of Milan

TD 5
Rapid ART initiation and Retention in care of people living with HIV: a six-years observational study in foreigners versus Italian-borne

×

Commento audio

Chiudi